Samsung Bioepis’ Etanercept Nod Prompts US Lawsuit

 
• By Penelope MacRae and Aidan Fry
  
Victory
Samsung Bioepis Has Received The Second US Nod For Biosimilar Etanercept • Source: Shutterstock

More from Regulation

More from Policy & Regulation